Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 42 of 3339 for:    China Medicine University Hospital

Dry Needling Treatment for Biceps Tendinopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03639454
Recruitment Status : Recruiting
First Posted : August 21, 2018
Last Update Posted : September 21, 2018
Sponsor:
Information provided by (Responsible Party):
Li-Wei Chou, China Medical University Hospital

Brief Summary:

Biceps tendinopathy is a common cause in shoulder-pain symptoms. The major mechanism is overuse of the biceps muscles. The long-term accumulated and poor repaired trauma causes myofascial trigger points in the related muscles.

We will conduct the randomized, single blind experiment to evaluate the immediate, short-term, and long-term effect of DN.


Condition or disease Intervention/treatment Phase
Bicep Tendinitis Procedure: dry needling Procedure: Transcutaneous electrical nerve stimulation Not Applicable

Detailed Description:

Biceps tendinopathy is a common cause in shoulder-pain symptoms. The major mechanism is overuse of the biceps muscles. The long-term accumulated and poor repaired trauma causes myofascial trigger points in the related muscles. Common symptoms are pain in the anterior shoulders and radiating pain in the biceps. Pain can be further elicited with lifting, pulling and repetitive overhead activity. Therefore, it can have a major impact on the patient's activity of daily life.

The investigator performed dry needle (DN) treatments with acupuncture needles. Stimulating the effected muscle , the investigator move the needle forward and backward several times. Muscle twitch may occur by our procedure. The pain caused by myofascial trigger points can be decreased effective simultaneously. So far, there is no solid research or clinical trial to evaluate the efficacy of the treatment yet.

The investigator will conduct the randomized, single blind experiment to evaluate the immediate, short-term, and long-term effect of DN. Outcome measures include visual analog scale, shoulder pain and disability index, pressure pain threshold, pain-free grip test, muscle tone changes and ultrasonographic evaluation of biceps peritendinous effusion.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect on Symptomatic Release of Dry Needling on Patients With Biceps Tendinopathy
Actual Study Start Date : September 18, 2018
Estimated Primary Completion Date : February 28, 2019
Estimated Study Completion Date : August 1, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tendinitis

Arm Intervention/treatment
Experimental: Dry needling
In this arm, the subjects will receive the intervention of DN on Day1, Day2 and Day4, in total 3 treatments and will be arrange to take efficacy two assessment on Day8 and Day15, separately.
Procedure: dry needling
Dry needling, also known as myofascial trigger point dry needling, is an well-proved technique in alternative medicine similar to acupuncture. It involves the use of either solid filiform needles or hollow-core hypodermic needles for therapy of muscle pain, including pain related to myofascial pain syndrome. Dry needling is sometimes also known as intramuscular stimulation (IMS).

Active Comparator: Transcutaneous Electric Nerve Stimulation
In this arm, the subjects will receive the intervention of Transcutaneous Electric Nerve Stimulation on Day1, Day2 and Day4, in total 3 treatments and will be arrange to take efficacy two assessment on Day8 and Day15, separately.
Procedure: Transcutaneous electrical nerve stimulation

Transcutaneous electrical nerve stimulation (TENS or TNS) is the use of electric current produced by a device to stimulate the nerves for therapeutic purposes.

TENS, by definition, covers the complete range of transcutaneously applied currents used for nerve excitation although the term is often used with a more restrictive intent, namely to describe the kind of pulses produced by portable stimulators used to treat pain. The unit is usually connected to the skin using two or more electrodes. A typical battery operated TENS unit is able to modulate pulse width, frequency and intensity. Generally TENS is applied at high frequency (>50 Hz) with an intensity below motor contraction (sensory intensity) or low frequency (<10 Hz) with an intensity that produces motor contraction.





Primary Outcome Measures :
  1. Visual Analog Scales [ Time Frame: 1 day ]
    The visual analogue scale or visual analog scale is a psychometric response scale which can be used in questionnaires. This tool used to help a person rate the intensity of certain sensations and feelings, such as pain. A straight line of 100mm is actually marked with 0 mm on the far left and 100mm on the far right. Two faces are drawn on both ends. Explain to the patient that 0 mm means no pain and 100 mm means very painful. From the left end The right shift indicates more and more pain. Take a pen and let the patient draw a short line vertically on the line, representing his painful position, and record the measured cm value. In this test, if the score of the subject decreases, it can represent the treatment is helpful for the improvement of the patient's pain.


Secondary Outcome Measures :
  1. Pressure Pain Threshold [ Time Frame: 1 day ]
    Pressure pain threshold (PPT) is defined as the minimum force applied which induces pain. This measure has proven to be commonly useful in evaluating tenderness symptom.

  2. Muscle tension [ Time Frame: 1 day ]
    Muscle tension is the muscle's resistance to passive stretch during resting state. The measuring tool called Myotone will calculate three parameters such as tone, elasticity and stiffness and get a value to represent the muscle tension. If the value decrease, it can represent the treatment is helpful for the subjective muscle relax.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Subjects older than 20 years of age who can cooperate with the experimental volunteers.
  2. Suffering from biceps tendon lesions for more than one month, and subjective pain intensity (VAS) greater than 5 points.
  3. There is a local tender point in front of the shoulder, and the shoulder joint pronation test can induce pain.
  4. Under soft tissue ultrasound, the thickness of Biceps Peritendinous Effusion (BPE) on the affected side of the biceps tendon is greater than 1 mm.

Exclusion Criteria:

  1. There are contraindications to general treatment, such as serious medical problems, recent serious trauma, or pregnant women.
  2. There has been a history of drug abuse (including excess alcohol) that affects pain assessors.
  3. Have received shoulder, neck or upper back surgery.
  4. People with central or peripheral nerve disease.
  5. Cognitive impairment, unable to cooperate with the experimenter.
  6. Patients currently receiving other treatments for Biceps tendinopathy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03639454


Contacts
Layout table for location contacts
Contact: LI-Wei Chou, PhD +886-4-22052121 ext 2381 chouliwe@mail.cmuh.org.tw
Contact: Ching-Hsuan Huang, MD +886-4-22052121 ext 1205 lauren8.huang@gmail.com

Locations
Layout table for location information
Taiwan
China Medical University Hospital Recruiting
Taichung, Taiwan, 999079
Contact: Chou Li-Wei, PhD    +886-4-22052121 ext 2381    chouliwe@mail.cmuh.org.tw   
Sponsors and Collaborators
China Medical University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Li-Wei Chou, PhD China Medical University Hospital

Layout table for additonal information
Responsible Party: Li-Wei Chou, Minister of Rehabilitation, China Medical University Hospital
ClinicalTrials.gov Identifier: NCT03639454     History of Changes
Other Study ID Numbers: CMUH107-REC2-101
First Posted: August 21, 2018    Key Record Dates
Last Update Posted: September 21, 2018
Last Verified: August 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Li-Wei Chou, China Medical University Hospital:
dry needling
myofascial trigger point
muscle tone

Additional relevant MeSH terms:
Layout table for MeSH terms
Tendinopathy
Muscular Diseases
Musculoskeletal Diseases
Tendon Injuries
Wounds and Injuries